These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. HL-A antigens in Behçet's disease. A family study. Nahir M; Scharf Y; Gidoni O; Brazilai A; Friedman-Birnbaum R; Haim S Dermatologica; 1978; 156(4):205-8. PubMed ID: 624430 [TBL] [Abstract][Full Text] [Related]
24. [Usefulness of the HLA-B5 system in Behçet's disease. Apropos of 93 typed cases]. Wechsler B; Le Thi Huong Du; Cabane J; Godeau P Presse Med; 1984 Feb; 13(5):285. PubMed ID: 6229783 [No Abstract] [Full Text] [Related]
25. Behçet's disease: lack of correlation of clinical manifestations with HLA antigens. Müftüoğlu AU; Yazici H; Yurdakul S; Pazarli H; Ozyazgan Y; Tüzün Y; Altaç M; Yalçin B Tissue Antigens; 1981 Feb; 17(2):226-30. PubMed ID: 7233417 [TBL] [Abstract][Full Text] [Related]
26. [Association of agramulocytosis caused by levamisole and HLA B27 in Behçet's disease]. Hamza M; Ben Ayed H Nouv Presse Med; 1979 Oct; 8(39):3167-8. PubMed ID: 537876 [No Abstract] [Full Text] [Related]
28. [Prognostic value of HLA B5 antigen in isolated anterior uveitis in Behçet's disease]. Oguz V; Pazarli H; Ozyazgan Y; Yazici H; Yurdakul S; Tuzun Y; Serdaroglu S J Fr Ophtalmol; 1989; 12(6-7):431-2. PubMed ID: 2636238 [No Abstract] [Full Text] [Related]
29. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes. Lehner T; Welsh KI; Batchelor JR Immunology; 1982 Dec; 47(4):581-7. PubMed ID: 6958639 [TBL] [Abstract][Full Text] [Related]
30. [Behçet's disease and HL-A antigens]. Miyajima T; Omori K; Aoki M; Yokoyama T; Hashizume T; Takano M; Okamoto S Nihon Rinsho; 1978 Sep; 36(9):3147-50. PubMed ID: 722914 [No Abstract] [Full Text] [Related]
31. Current concepts of Behçet's disease. Collum LM; Mullaney J; Bowell R Trans Ophthalmol Soc U K (1962); 1981; 101 (Pt 4)():422-8. PubMed ID: 6964263 [TBL] [Abstract][Full Text] [Related]
32. HLA B5 and Behçet's disease. Yazici H; Chamberlain MA; Schreuder GM; Bird-Stewart J; Denman M Ann Rheum Dis; 1983 Oct; 42(5):602-3. PubMed ID: 6625710 [No Abstract] [Full Text] [Related]
33. Close association of HLA-Bw51 with Behçet's disease. Ohno S; Ohguchi M; Hirose S; Matsuda H; Wakisaka A; Aizawa M Arch Ophthalmol; 1982 Sep; 100(9):1455-8. PubMed ID: 6956266 [TBL] [Abstract][Full Text] [Related]
35. [Characteristics of the distribution of major histocompatibility system antigens in retinal vasculitis in patients with Behçet's disease]. Ermakova NA Vestn Oftalmol; 2003; 119(1):31-3. PubMed ID: 12608042 [TBL] [Abstract][Full Text] [Related]
37. A study of HLA antigens in Behçet's syndrome. Lee S; Koh YJ; Kim DH; Bang D; Nam IW; Lee KH; Park K Yonsei Med J; 1988; 29(3):259-62. PubMed ID: 3195158 [No Abstract] [Full Text] [Related]
38. [Studies on HLA system of family members with Behçet's disease]. Ohno S; Ichiishi A; Awata K; Matsuda H Nippon Ganka Gakkai Zasshi; 1989 Feb; 93(2):215-7. PubMed ID: 2773703 [TBL] [Abstract][Full Text] [Related]
39. [Significance of the HLA complex in Behcet's disease]. Vadot E; Betuel H Bull Soc Ophtalmol Fr; 1977 Mar; 77(3):257-9. PubMed ID: 606385 [No Abstract] [Full Text] [Related]
40. Behçet disease and the HLA system. Takano M; Miyajima T; Kiuchi M; Ohmori K; Amemiya H Tissue Antigens; 1976 Aug; 8(2):95-9. PubMed ID: 968901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]